Congrats!!! Escellent presentations at #ASCO2026 and outstanding discussion @DrJudyBoughey Appropriate patient selection is key to achieving the best outcomes from surgical treatment de-escalation strategies.” happy @itrisabel to participate @EUBREAST

⭐ HER2 early breast cancer: de-escalation with precision ⭐ An important @OncoAlert exclusive for #ASCO26 with Dr. @JavierCortesMD discussing PHERGain and PHERGain-2. 🚨🎗️ These studies speak to one of the most relevant questions in early HER2 breast cancer: Can we safely personalize treatment intensity and reduce chemotherapy exposure in selected patients? A chemotherapy-free, pCR-guided strategy with dual HER2 blockade is not just about response. It is about smarter treatment selection, less toxicity, preserving quality of life, and moving de-escalation from concept to carefully tested clinical strategy. 🧬🩺 Looking forward to this discussion with the OncoAlert Breast faculty. 🌍🤝 @ElisaAgostinett @to_be_elizabeth @WeOncologists @ErikaHamilton9 @E_de_Azambuja @matteolambe @DrSGraff @hoperugo @BianchiniGP @Icro_Meattini @Lucarecco @GaiaGriguolo @aftimosp @double_whammied @stage4kelly @coffeemommy @itsnot_pink @maryam_lustberg @IBCResearch @kevinpunie @nicolobattisti @raalbany @teamoncology @stolaney1 @LoiSher @SirohiBhawna @chemobrainfog @jamecancerdoc @JaniceTNBCmets @Prof_Nadia_H @paspears88 @MammaMiaMagazin @itrisabel @wearemedsir #OncoAlert #ASCO26 #BreastCancer #HER2Positive #CancerCare

As we get started with #ASCO26, what better way to brush up with what has happened the last year in #BreastCancer Presentation 👉 buff.ly/l3G1CGn Get a 13 minute breakdown on ER Metastatic Breast Cancer from OncoAlert Faculty Dr. Erika Hamilton of Sarah Cannon🇺🇸 #BreastCancer @hoperugo 🇺🇸 @matteolambe 🇮🇹 @Icro_Meattini 🇮🇹 Dr. Roberto Salgado 🇧🇪 @ErikaHamilton9 🇺🇸 @DrSGraff 🇺🇸 @itrisabel 🇪🇸 @ESSOnews @ElisaAgostinett 🇧🇪 @RebeccaDSing 🇸🇬 @LazarPo31787807 🇷🇸 @aftimosp @to_be_elizabeth @GaiaGriguolo @Lucarecco Our Partners @ESGO_society @ESSOnews @CancerCareMASCC @SIOGorg

After a great day with sessions, multidisciplinary meetings, debates #EBCC15 ⁦@santpaubcn⁩ great place to share impressions about the EBCC ⁦@EORTC ⁦@europadonna⁩ @EUSOMA ⁦@HenryKuerer⁩ ⁦@itrisabel⁩ @michailignitiadis ⁦⁦@TanjaSpanic⁩

#EBCC15 is about to begin! A strong start with Isabel Rubio opening one of the most #multidisciplinary meetings in #breastcancer Looking forward to insightful discussions, collaboration, and progress for our patients #OncoAlert @EORTC_BCG @ESTRO_RT @OncoAlert @EuropaDonnaEUR

OncoAlert 🚨 Coverage of DAY ONE of #EBCC15 Breast Cancer and Communication: Patient Insights from Serbia Presented by Sara Bojanic An online survey conducted by Europa Donna Serbia in late 2024 among 810 women diagnosed with breast cancer reveals significant gaps in communication between patients and healthcare professionals in Serbia. Despite respondents being largely well educated, more than half reported receiving only partial information, limited time for discussion, and an incomplete understanding of their diagnosis and treatment options, often prompting them to seek information elsewhere. While the information provided was generally perceived as helpful, many patients felt insufficiently informed and unable to ask questions. The findings highlight an urgent need for clearer, more patient‑centred communication, improved health communication skills among professionals, and stronger patient involvement across the breast cancer care pathway. #BreastCancer @itrisabel @JavierCortesMD @MIgnatiadis @MichaelGnant @Icro_Meattini @matteolambe @c_sotiriou @aftimosp @MOliveira_MD @CarmenCriscit @lab_kok @to_be_elizabeth @ElisaAgostinett @Lucarecco @FernandoOnco @GaiaGriguolo @JankovicK @acampsmalea @kevinpunie @CarmineDeA1 @LauBuisseret

OncoAlert 🚨 Coverage of DAY ONE of #EBCC15 RAPCHEM Study Presented by Dr Fleur Mauritz A ten-year study shows that tailoring radiotherapy after chemotherapy and surgery to a patient’s individual risk keeps breast cancer recurrence rates very low while potentially reducing side-effects. In 848 patients treated in the Netherlands, radiotherapy was adjusted based on whether cancer remained in the lymph nodes after treatment, allowing some low‑risk patients to receive minimal or no radiotherapy. After a decade of follow‑up, only 2.9% experienced a local or regional recurrence, with similarly low rates across low-, intermediate- and high‑risk groups. The findings suggest that carefully stratifying patients by response to chemotherapy can safely reduce overtreatment and support more personalised breast cancer care. For the final conclusion, we will have to wait for the results of a randomised trial from the USA, which are expected in three years. #BreastCancer @itrisabel @JavierCortesMD @MIgnatiadis @MichaelGnant @Icro_Meattini @matteolambe @c_sotiriou @aftimosp @MOliveira_MD @CarmenCriscit @lab_kok @to_be_elizabeth @ElisaAgostinett @Lucarecco @FernandoOnco @GaiaGriguolo @JankovicK @acampsmalea @kevinpunie @CarmineDeA1 @LauBuisseret

Etienne Brain awarded at #EBCC15 👏 A well-deserved recognition followed by an insightful lecture on one of the most pressing issues in our field: treatment challenges and decision-making in elderly patients with #BreastCancer @EtienneB66 @OncoAlert #OncoAlert

A word from our Chair, Prof. @itrisabel At #EBCC15, this multidisciplinary spirit continues to shape discussions and drive progress in breast cancer care. Explore the searchable programme here 👉 cm.eortc.org/cmPortal/Search… @OncoAlert #BreastCancer

Launch of the SSO Career Catalyst Mentorship Program 2026-2027 cohort. Excited to be a mentor in this program @SocSurgOnc

📢 Late Breaking Abstracts submission for EBCC-15, just a few days left! Have new and impactful data to share? The submission period is open until 9 February 2026. 👉 Submit here: event.eortc.org/ebcc15/call-… #EBCC15 #BreastCancer #Research #Abstracts #Oncology

Celebrating World Cancer day!! Evidence based prevention strategies and treatments drives progress to reduce the burden of cancer!!

We are happy to join again the 2026 OncoAlert Colloquium! With ESSO reps presenting highlights in: ➡️ @itrisabel on #BreastCancer surgery ➡️ Johnn Henry Herrera Kok on lower #GIsurgery ➡️ Marco Inama on upper #GIsurgery

Dear Colleagues Coming February 2026: The 6th Annual OncoAlert Colloquium 🚨 REGISTER👉 oncoalert.m-pages.com/7I0mwF… Our Faculty List Keeps on Growing and As ALWAYS ✅Patients Included #BreastCancer @hoperugo🇺🇸 @matteolambe🇮🇹 @Icro_Meattini🇮🇹 Dr. Roberto Salgado 🇧🇪 @ErikaHamilton9 🇺🇸 @DrSGraff 🇺🇸 @itrisabel🇪🇸 @ESSOnews @ElisaAgostinett 🇧🇪 Dr. Fatima Cardoso 🇵🇹 @LazarPo31787807 🇷🇸 #LungCancer @GlopesMd🇺🇸 @jillfeldman4 @EGFRResisters🇺🇸 @UmbertoMalapel1 🇮🇹 @isliquidbiopsy @BRicciutiMD 🇺🇸 @gerryhanna 🇮🇪 @UOzkerim 🇹🇷 GU Oncology @brian_rini 🇺🇸 @declangmurphy 🇦🇺 @KidneyCancer🇺🇸 @salvolarosa @APCCC_Lugano🇨🇭 @RenuEapen🇦🇺 @nataliagandur 🇦🇷 @seanmcbride 🇺🇸 @GuardConsortium 🇪🇸 GI Oncology @BenWestphalen 🇩🇪 @florianlordick 🇩🇪 @NiuSanford 🇺🇸 @realbowtiedoc 🇺🇸 @ARosen380 🇺🇸 @Erman_Akkus 🇹🇷 John Herrera Kok Melanoma @DrBetofMDPhD 🇺🇸 Myeloma @Abdallah81MD 🇺🇸 Our Partners @ESGO_society @ESSOnews @CancerCareMASCC @SIOGorg Our Collaborators APCCC, GU CAST, Uromigos and more and more to come....... #OncoAlertAF @FernandoOnco @to_be_elizabeth @bavilima @GaiaGriguolo @JankovicK @MarioBalsaMD @DrMirallas @GIMedOnc @OscarTahuahua @DrRishabhOnco @Onco_Cifu88 @PaulJiL

Dear Colleagues Coming 1⃣st Week of February 2026: The 6th Annual OncoAlert Colloquium 🚨 REGISTER👉 buff.ly/UDfpkP8 Our Faculty List Keeps on Growing and As ALWAYS ✅Patients Included #BreastCancer @hoperugo🇺🇸 @matteolambe🇮🇹 @Icro_Meattini🇮🇹 Dr. Roberto Salgado 🇧🇪 @ErikaHamilton9 🇺🇸 @DrSGraff 🇺🇸 @E_de_Azambuja 🇧🇪 @itrisabel🇪🇸 ESSO @ElisaAgostinett 🇧🇪 Dr. Fatima Cardoso 🇵🇹 @ABCGlobalAll @LazarPo31787807 🇷🇸 #LungCancer @GlopesMd🇺🇸 @jillfeldman4 @EGFRResisters🇺🇸 @UmbertoMalapel1 🇮🇹 @isliquidbiopsy @BRicciutiMD 🇺🇸 @UOzkerim 🇹🇷 GU Oncology @brian_rini @Uromigos🇺🇸 @declangmurphy @gu_onc🇦🇺 @KidneyCancer🇺🇸 @APCCC_Lugano🇨🇭 @RenuEapen🇦🇺 @nataliagandur 🇦🇷 @seanmcbride 🇺🇸 GI Oncology @BenWestphalen 🇩🇪 @CathyEngMD 🇺🇸 @florianlordick 🇩🇪 @NiuSanford 🇺🇸 @realbowtiedoc 🇺🇸 @ARosen380 🇺🇸 @Erman_Akkus 🇹🇷 Melanoma @DrBetofMDPhD 🇺🇸 Our Partners @ESGO_society @ESSOnews @CancerCareMASCC @SIOGorg Our Collaborators APCCC, GU CAST, @Uromigos and more and more to come....... #OncoAlertAF @HHorinouchi @FernandoOnco @ElisaAgostinett @to_be_elizabeth @GaiaGriguolo @MarioBalsaMD @DrMirallas @GIMedOnc @DrRishabhOnco @Onco_Cifu88 @PaulJiL

A warm round of congratulations to our @OncoAlert #BreastCancer Faculty @stolaney1 🇺🇸 on receiving the @AACR Outstanding Investigator Award for Breast Cancer Research at #SABCS25 ! Beyond Proud! @matteolambe @aftimosp @E_de_Azambuja @DrSGraff @curijoey @ErikaHamilton9 @double_whammied @stage4kelly @coffeemommy @itsnot_pink @maryam_lustberg @IBCResearch @kevinpunie @raalbany @hoperugo @LoiSher @jamecancerdoc @JavierCortesMD @JaniceTNBCmets @Prof_Nadia_H @paspears88 @MammaMiaMagazin @itrisabel #OncoAlertAF @nataliagandur @acampsmalea @BRicciutiMD @HHorinouchi @FernandoOnco @ElisaAgostinett @to_be_elizabeth @bavilima @realbowtiedoc @Erman_Akkus @Lucarecco @GaiaGriguolo @JankovicK @MarioBalsaMD @DrMirallas @GIMedOnc @OscarTahuahua @UOzkerim @DrRishabhOnco @Onco_Cifu88 @PaulJiL @DaisukeKotani @DraMartinezLago

#EBCC15 unites multidisciplinary teams across Europe to share the latest in research, innovation & education. A unique chance to learn & collaborate with experts advancing breast cancer care. Follow us to stay informed. #BreastCancer #Oncology

Wishing all of our friends and colleagues 🌐 A Very #HappyThanksgiving2025 from @OncoAlert 🚨 @weoncologists @matteolambe @aftimosp @E_de_Azambuja @NicoleKuderer @FAndreMD @prat_aleix @DrSGraff @jesusanampa @StoverLab @curijoey @ErikaHamilton9 @double_whammied @stage4kelly @coffeemommy @itsnot_pink @maryam_lustberg @IBCResearch @kevinpunie @nicolobattisti @raalbany @hoperugo @teamoncology @stolaney1 @LoiSher @SirohiBhawna @chemobrainfog @jamecancerdoc @JavierCortesMD @JaniceTNBCmets @Prof_Nadia_H @paspears88 @MammaMiaMagazin @itrisabel @PatelOncology @weldeiry @CharlesSwanton @VivekSubbiah @HaanenJohn @jrgralow

⁦@EuropeanCancer⁩ #europeancancersummit the network on cancer workforce chaired by ⁦@WimCeelen⁩ #MarjanCrul updated strategies in Europe to improve continuous professional development

Improving equitable access to comprehensive care for people with advanced breast cancer: a global expert review and call-to-action for 2025–2035 (Goal 9) buff.ly/DDuvaTC Advanced #BreastCancer (ABC) remains treatable but incurable, and despite major therapeutic progress, global access to effective care is increasingly uneven. According to research for the ABC Global Alliance’s Global Decade Report 2.0, widening disparities in diagnostics, treatment infrastructure, drug supply, and reimbursement systems continue to delay and limit appropriate care, while high out-of-pocket costs create severe financial strain across all income levels. Nonetheless, collaborative, multi-stakeholder initiatives in low-resource settings are beginning to improve access. These findings have shaped the ABC Global Charter 2.0, which sets ten measurable goals for 2025–2035 to advance equity and outcomes for people living with ABC worldwide. @ABCGlobalAll @AlexEniu @runciecwc @GlopesMd @neciosup_silvia @nishapillayy @matteolambe @aftimosp @E_de_Azambuja @DrSGraff @ErikaHamilton9 @double_whammied @stage4kelly @coffeemommy @itsnot_pink @maryam_lustberg @IBCResearch @kevinpunie @nicolobattisti @raalbany @hoperugo @stolaney1 @LoiSher @JavierCortesMD @JaniceTNBCmets @Prof_Nadia_H @MammaMiaMagazin @itrisabel #OncoAlertAF @nataliagandur @acampsmalea @BRicciutiMD @FernandoOnco @ElisaAgostinett @to_be_elizabeth @bavilima @realbowtiedoc @Erman_Akkus @Lucarecco @GaiaGriguolo @JankovicK @JooMouta2 @MarioBalsaMD @DrMirallas @GIMedOnc @OscarTahuahua @UOzkerim @DrRishabhOnco @Onco_Cifu88